RVMD CEO Sells $1.3M Stock for Tax Withholding
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
RVMD CEO Sells $1.3M Stock for Tax Withholding
Company: Revolution Medicines, Inc. (RVMD) Form: 4 | Filed: 2026-03-19 Significance: Low
Insider: Mark A. Goldsmith Title: President and Chief Executive Officer | Relationship: Director/Officer
Transaction: • Type: Sale (Tax Withholding) • Shares: 12,871 • Price: $99.48 • Value: $1,280,412 • Owned After: 276,698 (Direct)
Key Insight: Routine sale mandated by a 10b5-1 plan to cover tax obligations associated with RSU vesting. Transaction represents <0.01% of market cap.
Market Context: Transaction is administrative in nature and does not reflect discretionary sentiment.
Comprehensive Analysis
SEC Filing Analysis: Revolution Medicines, Inc. (RVMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: CEO Mark Goldsmith sold shares solely to satisfy tax withholding obligations related to RSU vesting.
- Market Impact: Neutral; transaction is administrative and immaterial relative to market cap.
Company Information
| Field | Value |
|---|---|
| Company | Revolution Medicines, Inc. |
| Ticker Symbol | RVMD |
| CIK | 0001628171 |
| Industry | Biological Products |
Insider Information
| Field | Value |
|---|---|
| Name | Mark A. Goldsmith |
| CIK | 0001246842 |
| Title/Position | President and Chief Executive Officer |
| Relationship | Director/Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-17 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 12,871 |
| Price Per Share | $99.48 |
| Total Value | $1,280,412 |
| Shares Owned After | 276,698 (Direct) |
| Ownership Type | Direct & Indirect |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,280,412 |
| % of Market Cap | 0.0068% |
| Shares Transacted | 12,871 |
| % of Shares Outstanding | 0.0065% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $18.80 billion, a $1.28 million transaction is negligible.
- Ownership Concentration: The insider retains substantial ownership directly (276,698 shares) and indirectly via trusts (~722,908 shares).
- Transaction Significance: The transaction represents less than 0.01% of the company's outstanding shares.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing footnotes explicitly state the sale was made pursuant to a Rule 10b5-1 plan to satisfy tax withholding obligations. This is a "sell-to-cover" transaction, which is a standard administrative procedure for executive compensation and does not indicate bearish sentiment.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Special Circumstances: Footnote 1 clarifies this sale was to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and was executed under a 10b5-1 plan adopted on May 31, 2023.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.